Knights Of Columbus Asset Advisors LLC Novavax Inc Transaction History

Knights Of Columbus Asset Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$177.8 - $270.58 $606,120 - $922,407	-3,409 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $3,872 - $8,245	32 Added 0.95%	3,409 $724,000
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $381,533 - $1.08 Million	3,377 New	3,377 $612,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.